Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
AED 55.11
AED 4959.99AED 55.11
AED 660.99
60 tablet
Free AirMail shipping Hot
AED 58.78
AED 3527.05AED 58.78
AED 220.27
30 tablet
Free AirMail shipping Hot
AED 62.46
AED 1873.66AED 62.46
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
AED 66.13
AED 5952.02AED 66.13
AED 330.31
60 tablet
Free AirMail shipping Hot
AED 67.97
AED 4078.18AED 67.97
AED 110.04
30 tablet
Free AirMail shipping Hot
AED 69.80
AED 2094.11AED 69.80
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
AED 78.99
AED 7109.39AED 78.99
AED 330.31
60 tablet
Free AirMail shipping Hot
AED 80.83
AED 4849.76AED 80.83
AED 110.04
30 tablet
Free AirMail shipping Hot
AED 82.66
AED 2479.90AED 82.66
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.